Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Alpha Cognition Inc (ACOG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.70 -0.02    -2.78%
17/05 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 1
  • Bid/Ask: 0.60 / 0.72
  • Day's Range: 0.70 - 0.70
Alpha Cognition 0.70 -0.02 -2.78%

Alpha Cognition Inc Company Profile

 
Get an in-depth profile of Alpha Cognition Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Alpha Copper Corp. engages in acquiring, exploring, and developing mineral properties in British Columbia. The company explores for copper, gold, and molybdenum deposits. Its flagship properties are Indata property, which comprises 16 mineral claims covering an area of 3,189 hectares; and Okeover Property that consists of 12 mineral claims covering an area of 4,614 hectares in British Columbia, Canada. The company was formerly known as Prophecy Potash Corp. and changed its name to Alpha Copper Corp. in December 2021. Alpha Copper Corp. was founded in 2018 and is headquartered in Vancouver, Canada.Alpha Copper Corp. operates as a subsidiary of NorthWest Copper Corp.

Contact Information

Address 595 Burrard Street
Vancouver, V7X 1L4
Canada
Phone -
Fax -

Top Executives

Name Age Since Title
Darryl Jones 41 2020 President, CEO & Director
William Morton 73 2019 Independent Director
Sean Kingsley 41 2020 Director of Corporate Development & Director
Sean Charland 42 2022 Independent Director
Wesley Siemens - 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACOG Comments

Write your thoughts about Alpha Cognition Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell Feb 28, 2022 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alpha Cognition announced histology data from their intranasal Alpha-1062 traumatic brain injury (TBI) program. Essentially the results presented demonstrate that Alpha-1062 exhibits both neuroprotection and enhances restoration of sensory, motor and cognitive performance in this model of moderate traumatic brain injury.The histological results, in addition to positive functional data previously released, strongly support the further development of Alpha-1062 for TBI treatments. FYI - Alpha 0602, has been granted orphan drug designation which enables ACOG a 7-year marketing exclusivity and prohibits FDA approvals for similar drugs during this period.
Jeremy Lin
Jeremy Lin Nov 30, 2021 5:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Q3 results were as expected, with no surprise loss. Plus, the $5.6M in cash should continue to support the company well into next year. The stock is back into an uptrend despite the rough market condition over the past few days. And $ACOG's leading drug candidate, ALPHA-1062, has results set to be released early next year. I'm excited to see what the future holds.
Jeremy Lin
Jeremy Lin Nov 30, 2021 5:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Q3 results were as expected, with no surprise loss. Plus, the $5.6M in cash should continue to support the company well into next year. The stock is back into an uptrend despite the rough market condition over the past few days. And back $ACOG's leading drug candidate's, ALPHA-1062, results set to be released early next year, I'm expecting big things to come. https://www.businesswire.com/news/home/20211130005165/en/Alpha-Cognition-Reports-Third-Quarter-of-Fiscal-2021-Results
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email